Completed Series A financing
Started the setup of the 3000㎡ Phase I laboratory and the 2500㎡ CMC Center in Shenzhen
Completed the mRNA bio-engineering production workflow
Launched Phase I laboratory in Shenzhen R&D Center
Launched Hong Kong R&D center
Completed ~$800 million RMB (120 million USD) Series B financing
Submitted the 1st China patent
Signed the strategic partnership agreement with Chongqing Zhifei Biological Product Co., Ltd (the top vaccine enterprise in China)
Completed Angel financing
Submitted the 2nd China patent application
Signed the strategic partnership agreements with Chongqing Zhifei Biological Products Co., Ltd (the top vaccine enterprise in China) on mRNA vaccine
Submitted the 3rd China patent application
Completed the strategic investor financing
Company established